D2R | DNA to RNA is launching the next round of funding for the Translational Impact Research (TIR) program. This program supports a select few large-scale translational research projects in RNA-based therapeutics which are expected to have a measurable impact on the health of Canadians. Projects must address the D2R Initiative鈥檚 strategic priorities and priority disease areas: oncology, rare diseases, infectious diseases, cardiovascular and cardiometabolic diseases.

This competition is open to:

D2R | DNA to RNA is launching the next round of funding for the Translational Impact Research (TIR) program. This program supports a select few large-scale translational research projects in RNA-based therapeutics which are expected to have a measurable impact on the health of Canadians. Projects must address the D2R Initiative鈥檚 strategic priorities and priority disease areas: oncology, rare diseases, infectious diseases, cardiovascular and cardiometabolic diseases.

This competition is open to:

D2R | DNA to RNA is launching the next round of funding for the Translational Impact Research (TIR) program. This program supports a select few large-scale translational research projects in RNA-based therapeutics which are expected to have a measurable impact on the health of Canadians. Projects must address the D2R Initiative鈥檚 strategic priorities and priority disease areas: oncology, rare diseases, infectious diseases, cardiovascular and cardiometabolic diseases.

This competition is open to:

D2R | DNA to RNA is launching the next round of funding for the Translational Impact Research (TIR) program. This program supports a select few large-scale translational research projects in RNA-based therapeutics which are expected to have a measurable impact on the health of Canadians. Projects must address the D2R Initiative鈥檚 strategic priorities and priority disease areas: oncology, rare diseases, infectious diseases, cardiovascular and cardiometabolic diseases.

This competition is open to:

D2R | DNA to RNA is launching the next round of funding for the Translational Impact Research (TIR) program. This program supports a select few large-scale translational research projects in RNA-based therapeutics which are expected to have a measurable impact on the health of Canadians. Projects must address the D2R Initiative鈥檚 strategic priorities and priority disease areas: oncology, rare diseases, infectious diseases, cardiovascular and cardiometabolic diseases.

This competition is open to:

D2R | DNA to RNA is launching the next round of funding for the Translational Impact Research (TIR) program. This program supports a select few large-scale translational research projects in RNA-based therapeutics which are expected to have a measurable impact on the health of Canadians. Projects must address the D2R Initiative鈥檚 strategic priorities and priority disease areas: oncology, rare diseases, infectious diseases, cardiovascular and cardiometabolic diseases.

This competition is open to:

D2R | DNA to RNA is launching the next round of funding for the Translational Impact Research (TIR) program. This program supports a select few large-scale translational research projects in RNA-based therapeutics which are expected to have a measurable impact on the health of Canadians. Projects must address the D2R Initiative鈥檚 strategic priorities and priority disease areas: oncology, rare diseases, infectious diseases, cardiovascular and cardiometabolic diseases.

This competition is open to:

Simon Roy, Assistant Professor in the Department of Pathology, is one of four early-career clinician-scientists across Canada to receive the 2025 Clinician-Scientist Award from the Marathon of Hope Cancer Centres Network (MOHCCN).聽

Simon Roy, Assistant Professor in the Department of Pathology, is one of four early-career clinician-scientists across Canada to receive the 2025 Clinician-Scientist Award from the Marathon of Hope Cancer Centres Network (MOHCCN).聽

Simon Roy, Assistant Professor in the Department of Pathology, is one of four early-career clinician-scientists across Canada to receive the 2025 Clinician-Scientist Award from the Marathon of Hope Cancer Centres Network (MOHCCN).聽

Simon Roy, Assistant Professor in the Department of Pathology, is one of four early-career clinician-scientists across Canada to receive the 2025 Clinician-Scientist Award from the Marathon of Hope Cancer Centres Network (MOHCCN).聽

Simon Roy, Assistant Professor in the Department of Pathology, is one of four early-career clinician-scientists across Canada to receive the 2025 Clinician-Scientist Award from the Marathon of Hope Cancer Centres Network (MOHCCN).聽

Simon Roy, Assistant Professor in the Department of Pathology, is one of four early-career clinician-scientists across Canada to receive the 2025 Clinician-Scientist Award from the Marathon of Hope Cancer Centres Network (MOHCCN).聽

Simon Roy, Assistant Professor in the Department of Pathology, is one of four early-career clinician-scientists across Canada to receive the 2025 Clinician-Scientist Award from the Marathon of Hope Cancer Centres Network (MOHCCN).聽

Simon Roy, Assistant Professor in the Department of Pathology, is one of four early-career clinician-scientists across Canada to receive the 2025 Clinician-Scientist Award from the Marathon of Hope Cancer Centres Network (MOHCCN).聽

Chemicals used to replace bisphenol A (BPA) in food packaging can trigger potentially harmful effects in human ovarian cells, according to 黑料不打烊 University researchers.

A new study examined several chemicals commonly used in price stickers on packaged meat, fish, cheese and produce found early signs of potential toxicity.

Chemicals used to replace bisphenol A (BPA) in food packaging can trigger potentially harmful effects in human ovarian cells, according to 黑料不打烊 University researchers.

A new study examined several chemicals commonly used in price stickers on packaged meat, fish, cheese and produce found early signs of potential toxicity.

Chemicals used to replace bisphenol A (BPA) in food packaging can trigger potentially harmful effects in human ovarian cells, according to 黑料不打烊 University researchers.

A new study examined several chemicals commonly used in price stickers on packaged meat, fish, cheese and produce found early signs of potential toxicity.

Chemicals used to replace bisphenol A (BPA) in food packaging can trigger potentially harmful effects in human ovarian cells, according to 黑料不打烊 University researchers.

A new study examined several chemicals commonly used in price stickers on packaged meat, fish, cheese and produce found early signs of potential toxicity.

Chemicals used to replace bisphenol A (BPA) in food packaging can trigger potentially harmful effects in human ovarian cells, according to 黑料不打烊 University researchers.

A new study examined several chemicals commonly used in price stickers on packaged meat, fish, cheese and produce found early signs of potential toxicity.